drugset / Trial / NCT00310505

Amphotericin B Treatment in Visceral Leishmaniasis

NCT00310505

Completed 1500 enrolled Banaras Hindu University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.

Timeline

Start
2003-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Amphotericin B Unknown 0.75 mg/kg
Subject Amphotericin B Unknown 1 mg/kg